Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

No phase data

Trial Status

Other2

Role Distribution

Principal Investigator2
PI Rate100%

Activity Timeline

Clinical Trials (2)

NCT03335670Early Phase 1Active Not Recruiting
Gallium 68 Pentixafor in Patients With Neuroendocrine Tumors
Neuroendocrine Tumors
PrincipalinvestigatorStart date: 2017-11-03
NCT05557708Early Phase 1Not Yet Recruiting
A Safety Study of 212Pb-Pentixather Radioligand Therapy
Carcinoid Tumor LungCarcinoma, Small-Cell LungNeuroendocrine Tumor of the Lung
Principalinvestigator

Research Network

Collaboration Network

2 collaborators·1 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Research Areas & Affiliations

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Michael B Gill

Power Life Sciences Inc.

Related
105 trials

Shared therapeutic areas:

Neuroendocrine TumorsSmall Cell Lung Carcinoma
Similarity Score15%

M. Sue O'Dorisio, MD, PhD

University of Iowa

Related
4 trials

Shared therapeutic areas:

Neuroendocrine Tumors

Worked with same sponsors:

Holden Comprehensive Cancer CenterNational Cancer Institute (NCI)+2 more
Collaborated on 1 trial
Similarity Score14%

David R. Spigel, MD

SCRI Development Innovations, LLC

Related
11 trials

Shared therapeutic areas:

Small Cell Lung Carcinoma
Similarity Score8%

Anish Thomas, M.D.

National Cancer Institute (NCI)

Related
9 trials

Shared therapeutic areas:

Small Cell Lung Carcinoma

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score8%

Steven A Rosenberg, M.D.

National Cancer Institute (NCI)

Related
32 trials

Shared therapeutic areas:

Neuroendocrine Tumors

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score8%

Yifan Zhai, MD, PhD

Ascentage Pharma Group Inc.

Related
14 trials

Shared therapeutic areas:

Small Cell Lung Carcinoma
Similarity Score8%

Neeta Pandit-Taskar, MD

Memorial Sloan Kettering Cancer Center

Related
8 trials

Shared therapeutic areas:

Neuroendocrine Tumors
Similarity Score8%

You Lu, MD

West China Hospital

Related
18 trials

Shared therapeutic areas:

Small Cell Lung Carcinoma
Similarity Score8%

Brennan Spiegel, MD, MSHS

Cedars-Sinai Medical Center

Related
10 trials

Shared therapeutic areas:

Neuroendocrine Tumors

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score8%

Francesco Perrone, M.D., Ph.D

National Cancer Institute Naples, Italy; Director Clinical Trials Unit

Related
9 trials

Shared therapeutic areas:

Small Cell Lung Carcinoma
Similarity Score8%

Publications (0)

No publications found for this investigator.

Clinical Trials (2)

Showing 2 of 2 trials

NCT03335670Early Phase 1PrincipalInvestigator

Gallium 68 Pentixafor in Patients With Neuroendocrine Tumors

Neuroendocrine Tumors
Active Not Recruiting
NCT05557708Early Phase 1PrincipalInvestigator

A Safety Study of 212Pb-Pentixather Radioligand Therapy

Carcinoid Tumor LungCarcinoma, Small-Cell LungNeuroendocrine Tumor of the Lung
Not Yet Recruiting

All 2 trials loaded